- Home
- NUS vs THW Comparison
NUS vs THW Comparison
Compare NUS & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NUS | THW |
|---|---|---|
| Founded | 1984 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 469.0M | 514.7M |
| IPO Year | 1996 | 2015 |
Fundamental Metrics
Financial Performance| Metric | NUS | THW |
|---|---|---|
| Price | $8.45 | $12.73 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 527.1K | 142.7K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.78% | N/A |
| EPS Growth | ★ 207.80 | N/A |
| EPS | ★ 3.18 | N/A |
| Revenue | ★ $3,176,718,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.14 | N/A |
| P/E Ratio | $2.72 | ★ N/A |
| Revenue Growth | ★ 48.98 | N/A |
| 52 Week Low | $5.32 | $9.80 |
| 52 Week High | $14.62 | $13.19 |
Technical Indicators
Market Signals| Indicator | NUS | THW |
|---|---|---|
| Relative Strength Index (RSI) | 33.28 | 53.26 |
| Support Level | $8.10 | $12.33 |
| Resistance Level | $8.73 | $12.83 |
| Average True Range (ATR) | 0.36 | 0.16 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 9.56 | 68.63 |
Price Performance
Historical ComparisonAbout NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.